SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 201 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $116,000 | +728.6% | 28,019 | +1081.7% | 0.00% | – |
Q1 2022 | $14,000 | -69.6% | 2,371 | -60.9% | 0.00% | -100.0% |
Q4 2021 | $46,000 | -67.1% | 6,070 | -48.2% | 0.00% | -60.0% |
Q2 2021 | $140,000 | +3400.0% | 11,715 | +3844.4% | 0.01% | – |
Q1 2021 | $4,000 | -91.5% | 297 | -90.1% | 0.00% | -100.0% |
Q4 2020 | $47,000 | +4600.0% | 2,989 | +1803.8% | 0.00% | – |
Q1 2019 | $1,000 | 0.0% | 157 | +101.3% | 0.00% | – |
Q4 2018 | $1,000 | -91.7% | 78 | -87.5% | 0.00% | -100.0% |
Q1 2018 | $12,000 | +1100.0% | 622 | +776.1% | 0.01% | +500.0% |
Q3 2017 | $1,000 | -87.5% | 71 | -92.5% | 0.00% | -87.5% |
Q2 2017 | $8,000 | – | 942 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
EMC Capital Management | 48,992 | $765,000 | 0.58% |
Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |